BIOMARIN PHARMACEUTICAL INC

CUSIP: 09061GAH4 Class: Convertible Debt

OAKTREE CAPITAL MANAGEMENT LP's Holding History (CIK: 0000949509)

Note: Option positions (PUT/CALL) are excluded.

Q2 2024
Shares 2,936,000 Value ($000) $2,919 Avg Close — Range —
Q4 2023
Shares 7,867,000 Value ($000) $7,773 Avg Close — Range —
Q2 2023
Shares 4,448,000 Value ($000) $4,380 Avg Close — Range —
Q1 2023
Shares 6,561,000 Value ($000) $6,748 Avg Close — Range —
Q4 2022
Shares 2,463,000 Value ($000) $2,620 Avg Close — Range —
Q3 2022
Shares 1,700,000 Value ($000) $1,688 Avg Close — Range —
Q2 2022
Shares 1,700,000 Value ($000) $1,687 Avg Close — Range —
Q1 2022
Shares 3,500,000 Value ($000) $3,507 Avg Close — Range —
Q4 2021
Shares 4,103,000 Value ($000) $4,300 Avg Close — Range —
Q3 2021
Shares 4,198,000 Value ($000) $4,305 Avg Close — Range —
Q2 2021
Shares 8,500,000 Value ($000) $8,829 Avg Close — Range —
Q1 2020
Shares 470,000 Value ($000) $493 Avg Close — Range —
Q4 2019
Shares 3,500,000 Value ($000) $3,706 Avg Close — Range —
Q1 2019
Shares 2,100,000 Value ($000) $2,154 Avg Close — Range —
Q4 2018
Shares 7,400,000 Value ($000) $7,377 Avg Close — Range —
Q3 2018
Shares 18,865,000 Value ($000) $20,150 Avg Close — Range —
Q2 2018
Shares 30,500,000 Value ($000) $30,887 Avg Close — Range —
Q3 2017
Shares 4,953,000 Value ($000) $5,042 Avg Close — Range —